Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Toripalimab plus nab-paclitaxel in metastatic or recurrent triple-negative breast cancer: a randomized phase 3 trial

PaperCitations, authors & open-access status

Toripalimab plus nab-paclitaxel in metastatic or recurrent triple-negative breast cancer: a randomized phase 3 trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 120 citations, 2024 year and closed oa status.

120
Citations
2024
Year
closed
OA Status

Related on ScholarIQ

Yongqiang Zhang
Author
Nature Medicine
Journal
Cancer Immunotherapy and Biomarkers
Topic
Cancer Immunotherapy and Biomarkers
Topic
Advanced Breast Cancer Therapies
Topic
Lung Cancer Treatments and Mutations
Topic
470M+ articles · free account